Used for reconstitution of lyophilized research compounds in vitro
Like all raw cosmetic actives, this product should be incorporated into a finished formulation at the recommended usage rate
Theoretical and route-specific risks FDA's 2024 review specifically flagged that no published human exposure data exists for the subcutaneous, transdermal, or intranasal routes that compounding pharmacies have offered
It was shown that long-term treatment (72 h) of hippocampal slices with BDNF (250 ng/mL) increases synapse number and spine density at the level of apical dendrites of pyramidal neurons in the hippocampus [35], suggesting that BDNF acts selectively on different types of spines, depending on the level of basal, spontaneous synaptic transmission
Disclaimer: This article is for educational and informational purposes only and describes preclinical and laboratory research
For the LA-treated groups vs